Balancing the Risks and Benefits of Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery.

Authors :: Rao, Sunil V.
Ohman, E. Magnus
Source :: JAMA: Journal of the American Medical Association. 8/9/2022, Vol. 328 Issue 6, p532-533. 2p.
Publication Year :: 2022
Abstract: When considering whether and how to use to DAPT after CABG surgery, it is instructive to consider both the indication for CABG surgery and the pathophysiology of SVG failure. Editorial Coronary artery bypass graft (CABG) surgery is the second most common method of coronary artery revascularization after percutaneous coronary intervention (PCI). [Extracted from the article]

Subjects :: *CORONARY artery bypass
*RISK assessment
*PLATELET aggregation inhibitors

Full Text Access

Tools